Web www.bestsyndication.com
Match.com


 

Subscribe to our news

Enter your email address:


Add to Google
Add to My AOL  


Prostate

Low Oxygen in Cells might spur Cancer Growth

| | | | | | | |
Breast Cancer in the Pleural Fluid credit: National Cancer Insitute Dr. Lance Liotta Laboratory - PD

(Best Syndication News) - The tumor growth rate of certain cancers could be increased with low oxygen levels, according to recent study from researchers at the University of Georgia. The study was published in the early online edition of the Journal of Molecular Cell Biology.

The current consensus of most researchers is that genetic mutation is the main cause of cancer growth. This study suggests another cause: low oxygen levels (hypoxia) in cells. Oxygen may play a role in unruly tumor growth in certain types of cancer. Prior research showed that low oxygen levels were a contributing factor to cause cancer to advance, however, they did not point to it as the main cause.

Share/Save/Bookmark
       Post to Facebook

2012 California County Health Report released by CDPH

| | | | | | | | | | | | | | | | | | |
County Population Dark Orange is over 900,000, medium orange is 300,000 to 900,000 and lightest yellow is under 300,000 people - credit CDPH.gov report

(Best Syndication News) - The California Department of Public Health has released their County Health Status Profiles 2012 report that assesses the health status of each county throughout the state. The current data analyzed was between 2008 – 2010 and was compared against the Healthy People 2010 National Objectives to determine if the state has met each goal.

The CDPH report saw improvements from the previous report that involved the years of 2005 through 2007. The new report saw around a 14 percent decline in the birthrates of adolescent mothers for the 2008 through 2010 data. There was a 29.4 percent reduction in motor vehicle traffic crash death rates, which was the best improvement overall in the 2012 report. The rates of Gonorrhea infections declined by 25.6 percent. AIDS infections declined by 24.4 percent. Diabetes death rates also showed a decline by 11.1 percent. All cancers including lung, breast, and prostate declined since the 2005 – 2007 report. There also was a reduction in coronary heart disease, and cerebrovascular disease. However, death rates for Alzheimer’s disease and suicide rates increased.

Share/Save/Bookmark
       Post to Facebook

Medivation Shares rise after Positive Results from Prostate Drug Trial

| | | | | | | |
alt text

(Best Syndication News) –Medivation, Inc. (NASDAQ: MDVN) shares increased 21.95 percent, up $12.16 to close at $67.57. The share price climbed Wednesday, after of positive results with the Phase 3 AFFIRM trial for a drug to treat prostate cancer. Medivation is working with Japan based Astellas Pharma Inc. (TYO: 4503) on the development of the MDV3100 investigational drug.

Data from the trial showed that MDV3100 provided an average 4.8 month life extension compared to the placebo group. The data will be presented at the 2012 Genitourinary Cancers Symposium in San Francisco, CA this Thursday, February 2.

Share/Save/Bookmark
       Post to Facebook

Disease Prevention tips on ‘The Dr. Oz Show’

| | | | | | | | | | | | | | | | |
credit: National Cancer Institute - PD

(Best Syndication News) - Dr. Oz hosted a special ‘Prevention Power Hour’ on his TV show today and said it is never too late to prevent disease. By changing how you do things you can reduce your risk of developing heart disease by up to 80 percent, cancer up to 60 percent, and type 2 diabetes up to 90 percent, he explained. Two doctors join him on the show to explain simple lifestyle changes that can prevent diseases. Later on, Dr. Oz had Health Magazine editor, Frances Largeman-Roth, RD, shared some unique household products that can offer health prevention - all for under $10.

Donald Hensrund, Md, chair Preventive Medicine at the Mayo Clinic and said that preventive medicine, helps people make lifestyle changes to feel better now and live longer.

Share/Save/Bookmark
       Post to Facebook

Citalopram and Finasteride Recall announced because of label mixup says FDA

| | | | | | |
Citalopram and Finasteride Recall announced because of label mixup says FDA

Best Syndication News

(Best Syndication News) - The US Food and Drug Administration (FDA) announced a recall for citalopram and finasteride prescription medications because the wrong labels may have been put on these bottles mixing the two of them up. Greenston LLC, a subsidiary of Pfizer, is the manufacturers of these two medications that involved in this recall.

The list of recalled citalopram and finasteride prescription drugs are as follows:

• Citalopram 10 mg Tablets (100-count bottle), lot number FI0510058-A

• Finasteride 5 mg Tablets (90-count bottle), lot number FI0510058-A

Share/Save/Bookmark
       Post to Facebook
Syndicate content


Important: The material on Best Syndication is for informational purposes only and is not meant to be advice. Authors may have or will receive monetary compensation from the company's product/s mentioned. You should always seek professional advice before making any legal, financial or medical decisions and this website cannot substitute or replace any trained professional consultation. Use of this site means that you agree to our TERMS OF SERVICE


Advertise On This Site

Copyright © 2006-2014 By Best Syndication All Rights Reserved

Enter your email address:

Subscribe to our

Local News